Abstract
Actinic keratoses (AKs) are evolving, malignant cutaneous neoplasms. AKs can be treated with physical or destructive methods and by topical therapies. This article is the second in a 2-part series of current topical therapeutic options for AKs and discusses topical diclofenac, colchicine, and retinoids. The first part focused on topical 5-fluorouracil and imiquimod.
MeSH terms
-
Administration, Cutaneous
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
Colchicine / administration & dosage
-
Colchicine / therapeutic use*
-
Diclofenac / administration & dosage
-
Diclofenac / therapeutic use*
-
Humans
-
Keratolytic Agents / administration & dosage
-
Keratolytic Agents / therapeutic use
-
Keratosis / drug therapy*
-
Keratosis / pathology
-
Precancerous Conditions / drug therapy
-
Precancerous Conditions / pathology
-
Randomized Controlled Trials as Topic
-
Retinoids / administration & dosage
-
Retinoids / therapeutic use*
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antineoplastic Agents
-
Keratolytic Agents
-
Retinoids
-
Diclofenac
-
Colchicine